simvastatin has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chade, AR; Lavi, R; Lerman, A; Lerman, LO; Lin, J; Zhu, XY | 1 |
| Chade, AR; Daghini, E; Lerman, A; Lerman, LO; Napoli, C; Ritman, EL; Zhu, XY | 1 |
2 other study(ies) available for simvastatin and Goldblatt Syndrome
| Article | Year |
|---|---|
Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cell Survival; Disease Models, Animal; Endothelial Cells; Fibrosis; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension, Renovascular; Inflammation; Kidney; Lipoproteins, LDL; Macrophages; Oxidative Stress; Renal Circulation; Simvastatin; Stem Cells; Sus scrofa | 2010 |
Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs.
Topics: Animals; Coronary Vessels; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renovascular; Microcirculation; Neovascularization, Physiologic; Simvastatin; Swine; Tumor Necrosis Factor-alpha | 2007 |